Chronic Plaque Psoriasis (Ps) Registry

Completed

Conditions studied: Chronic Plaque Psoriasis

In brief

The purpose of this study is to evaluate the long-term safety of Humira® in Adult Patients with Chronic Plaque Psoriasis (Ps).

Key facts

Study ID

NCT00799877

Run by

AbbVie

People needed

6065

Starts

2008-09-26

Expected to finish

2023-02-13

Last updated by the study team

2024-03-15

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• An adult patient (18 years of age or older) with chronic plaque psoriasis who has been prescribed HUMIRA® therapy according to the local product labeling and meets one of the following criteria:
• New initiated (within 4 weeks of registry entry) on HUMIRA® therapy;
• Initiated HUMIRA® therapy in the past and:
• Has received continuous (no more than 70 consecutive days off drug) HUMIRA® therapy and the physician can provide source documentation of SAEs, AEs, of Special Interest, and dosing information since initiation of therapy.
• OR
• Is entering after participation in an AbbVie HUMIRA (adalimumab) sponsored study and has received continuous (no more than 70 consecutive days off drug) HUMIRA® therapy after the completion of AbbVie sponsored study and physician can provide source documentation of SAEs, AEs of Special Interest, and dosing information since initiation of commercial HUMIRA® (defined as a prescribed/non study drug).
• Patient is willing to consent to data being collected and provided to AbbVie;
• Patient is capable of and willing to give written informed consent and to comply with the requirements of the registry.

You may not qualify if…

• Patient should not be enrolled if he/she cannot be treated in accordance with the local product label.

Where it is running

• Total Skin and Beauty Derm Ctr /ID# 17156 — Birmingham, Alabama, United States
• Inverness Dermatology /ID# 76194 — Birmingham, Alabama, United States
• McLain Medical Associates, PC /ID# 18351 — Birmingham, Alabama, United States
• Deep South Dermatology, PC /ID# 40267 — Daphne, Alabama, United States
• Northeast Alabama Dermatology /ID# 76193 — Huntsville, Alabama, United States
• Yates, Huntsville, AL /ID# 17130 — Huntsville, Alabama, United States
• Mobile Dermatology, P.C. /ID# 19783 — Mobile, Alabama, United States
• Medical Dermatology Specialist /ID# 76113 — Phoenix, Arizona, United States
• Arizona Advanced Dermatology /ID# 20512 — Phoenix, Arizona, United States
• Camelback Dermatology & Skin Surgery /ID# 18901 — Phoenix, Arizona, United States
• Alliance Dermatology and MOHs Center, PC /ID# 17087 — Phoenix, Arizona, United States
• Omni Dermatology Research /ID# 135562 — Phoenix, Arizona, United States
• Affiliated Dermatology /ID# 18327 — Scottsdale, Arizona, United States
• Specialists in Dermatology /ID# 18864 — Tucson, Arizona, United States
• Johnson Dermatology Clinic /ID# 17088 — Fort Smith, Arkansas, United States
• Hull Dermatology, PA /ID# 17086 — Rogers, Arkansas, United States
• Elite MD Adv Derm Laser /ID# 28323 — Danville, California, United States
• Center for Dermatology Clinical Research /ID# 20722 — Fremont, California, United States
• Associates in Research /ID# 17544 — Fresno, California, United States
• Dermatology and Dermatologic /ID# 17145 — Garden Grove, California, United States
• Guagenti, Glendale, CA /ID# 28263 — Glendale, California, United States
• Miremadi Dermatology /ID# 24323 — La Jolla, California, United States
• SCRIPPS Clinic /ID# 28147 — La Mesa, California, United States
• Dr. Abdallah Khourdaji /ID# 24307 — Lodi, California, United States
• Southview Medical Group, PC /ID# 20961 — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.